ADEPT 12/14 Modular Head (Used as femoral head component in metal on metal (MoM) total hip arthroplasty) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Johnson & Johnson Medical Pty Ltd T/A Depuy Australia 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00054-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2013-02-25
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Review of post-market surveillance data suggests a higher than expected revision rate for the adept® 12/14 modular head used in conventional total hip arthroplasty (tha). in september 2012 the aoa njrr reported a cumulative revision rate of 7.1% (95% ci 3.6% to 13.6%) at 3 years with 8 revisions in a cohort of adept® cases (adept® cups used in conjunction with adept® 12/14 modular heads) used in conventional total hip arthroplasty. the identified reasons for the revisions are 4 loosening/lysis, 2 infections, 1 prosthesis dislocation and 1 pain. an analysis of uk njr data (download 11th november 2012) indicated a cumulative revision rate of 12.1% (95% ci 9.5% to 15.4%) at 7 years for the adept® 12/14 modular head when used in conventional total hip arthroplasty based on 109 revisions from 1582 recorded procedures. when this combination is used with the adept® cementless stem, the data showed a cumulative revision rate of 9.7% (95% ci 5.9% to 15.5%) at five years.
  • 조치
    J&J; is advising implanting/treating surgeons on how to manage patients implanted with the Adept 12/14 Modular Head. For more information, please see http://www.tga.gov.au/safety/alerts-device-hip-ahm-130318.htm .

Device

  • 모델명 / 제조번호(시리얼번호)
    ADEPT 12/14 Modular Head (Used as femoral head component in metal on metal (MoM) total hip arthroplasty)All product codesAll lots are affectedARTG Number: 115691
  • Manufacturer

Manufacturer